Concepedia

Maor Sheva

MS

2

Publications

119

Citations

2

H-Index

2017

Active since

Affiliations

Protalix BioTherapeutics (Israel)(Current)

Maor Sheva is an author at Protalix BioTherapeutics (Israel) specializing in biotechnology, biomolecular engineering, and genome editing.

Top concepts

Publications per year

2017–2020

2

Publications

2

Establishment of a tobacco BY2 cell line devoid of plant‐specific xylose and fucose as a platform for the production of biotherapeutic proteins

Uri Hanania, Tami Ariel, Yoram Tekoah et al. · Plant Biotechnology Journal · 2017 · 108 citations · Full text

, , +22

Sequential Genome Editing and Induced Excision of the Transgene in N. tabacum BY2 Cells

Maor Sheva, Uri Hanania, Tami Ariel et al. · Frontiers in Plant Science · 2020 · 11 citations · Full text

Rows per page

1–2 of 2